Abeona Therapeutics Inc.
ABEO· Nasdaq
Released Mar 30, 2017, after the close
10-K filed Mar 30, 2017, 89 days after period end · 0001144204-17-017709
derived · Computed from the longer spans the company filed.
No earnings release is on file for this quarter. Its figures came with the 10-K.
| Metric | Q4 2016dderived from reported figures | Q4 2015dderived from reported figures | Q4 2014dderived from reported figures | Q4 2013dderived from reported figures |
|---|---|---|---|---|
| Revenue | $256.00K | $215.00K | $234.00K | $162.00K |
| Net Income | -$7.00M | -$2.34M |
Abeona Therapeutics Inc. · CIK 318306 · Engraved from SEC EDGAR
| -$11.94M |
| -$1.08M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.